Saturday
SESSION 42: NEW DEVELOPMENTS IN TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS)
Moderators:Ross Milner, MD / Jean-Pierre Becquemin, MD, FRCS  
SESSION 42 SCHEDULE
8:13 AM - 8:18 AM How Does Transcatheter Intra-arterial Denervation Work: Who Should Be Treated And Who Should Not: Why Is The Artery Not Injured And Are There Dangers From The Treatment
  Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD  
8:19 AM - 8:24 AM What Are The Secondary Benefits – Other Than Reducing Blood Pressure – To Renal Denervation: When Will This Treatment Be Available In The US And How Long Will All Benefits Last
  Presenter(s):Michael R. Jaff, DO / Ido Weinberg, MD, MSc  
8:25 AM - 8:30 AM Status Of Renal PTA And Stenting After ASTRAL And CORAL: What’s New In The Field
  Presenter(s):Thomas A. Sos, MD  
8:31 AM - 8:36 AM Frontiers In Renal Artery Stenting: What Does The Future Hold: Better Stents, Better Balloons, Etc.
  Presenter(s):Max Amor, MD  
8:37 AM - 8:42 AM Long-Term Outcomes Of PTA And/Or Stenting For Renal Fibromuscular Hyperplasia: What Is The Best Treatment
  Presenter(s):Albeir Y. Mousa, MD / Ali F. AbuRahma, MD  
8:43 AM - 8:48 AM Best Method To Assess SMA Stents: How Does Duplex Correlate With Pressure Measurements, CTA And Clinical Outcomes
  Presenter(s):Timothy A. Resch, MD, PhD  
8:49 AM - 8:54 AM Early And Late Outcomes Of PTA And Stenting Of Celiac And SMA Occlusive Disease: Advantages, Limitations And Results Up To 10 Years
  Presenter(s):Ali F. AbuRahma, MD  
  View Abstract      
8:55 AM - 9:00 AM Can The Results Of Mesenteric Revascularization Improve With Covered Stents And Distal Protection Devices
  Presenter(s):Gustavo S. Oderich, MD, FACS  
9:01 AM - 9:06 AM How To Treat Isolated SMA Dissections: When Medical vs. Interventional vs. Surgical Therapy
  Presenter(s):Young Wook Kim, MD  
  View Abstract      
9:07 AM - 9:13 AM Panel Discussion
Moderator(s): Enrico Ascher, MD / James C. Stanley, MD  
9:14 AM - 9:19 AM DEBATE: Treatment Of Mid-Aortic Syndrome In Young Adults: Interventional Treatment Is Indicated In Some
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
9:20 AM - 9:25 AM DEBATE: Interventional Therapy Is Never Indicated For Mid-Aortic Syndrome At Any Age: Open Surgery Is Best
  Presenter(s):Wilhelm Sandmann, MD  
9:26 AM - 9:31 AM When Are Reentry Devices And Covered Stents Needed For Iliac Occlusive Lesions
  Presenter(s):Jörn O. Balzer, MD, PhD  
9:32 AM - 9:37 AM DEBATE: Open Surgery Is Still Needed For Some Aortoiliac Occlusive Lesions: Which Ones
  Presenter(s):Michel S. Makaroun, MD  
9:38 AM - 9:43 AM DEBATE: Endovascular Treatment Is Best For All Aortoiliac Occlusive Lesions
  Presenter(s):Martin Malina, MD, PhD  
9:44 AM - 9:49 AM Endovascular Treatment Of Juxtarenal Aortic Occlusions Should Always Be Possible Using Chimneys And Other Adjuncts
  Presenter(s):Sonia Ronchey, MD / Nicola Mangialardi, MD  
9:50 AM - 9:55 AM Use Of Advanta V12 Covered Stents For Endovascular Reconstruction Of The Aortoiliac Bifurcation To Treat Complex Occlusive Lesions
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
  View Abstract      
9:56 AM - 10:20 AM Panel Discussion And Break
Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 42
previous next